2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Revenue | $1.6B | $1.8B | $2.3B | $2.1B | $2.2B |
Cost of Revenue | $998M | $1.1B | $1.4B | $1.2B | $1.2B |
Gross Profit | $563M | $726M | $908M | $893M | $1B |
Gross Profit % | 36% | 39% | 40% | 43% | 46% |
R&D Expenses | $3M | $12M | $13M | $15M | $0 |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Net Income | $27M | $25M | $42M | -$39M | $42M |
Dep. & Amort. | $103M | $118M | $139M | $142M | $144M |
Def. Tax | -$781K | -$9.7M | -$4.5M | -$22M | -$18M |
Stock Comp. | $9M | $9.8M | $12M | $11M | $16M |
Chg. in WC | $3.3M | -$81M | -$252M | -$153M | -$293M |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Cash | $71M | $157M | $61M | $450M | $60M |
ST Investments | $0 | $0 | $0 | $0 | $0 |
Cash & ST Inv. | $71M | $157M | $61M | $450M | $60M |
Receivables | $207M | $278M | $298M | $318M | $444M |
Inventory | $363M | $562M | $732M | $740M | $962M |
CODI reported strong financial results for 2024, achieving double-digit sales growth and a 30%+ increase in adjusted EBITDA, with Q4 performance exceeding expectations.
The company strategically acquired Honeypot and LifeFone while divesting Ergobaby and Crosman Airgun to focus on innovative, high-growth businesses.
CODI raised $115M in preferred equity and reduced its leverage ratio to 3.58x, with plans to further deleverage and reinvest in growth opportunities.
For 2025, CODI expects consolidated adjusted EBITDA between $480M-$520M and adjusted earnings of $170M-$190M, with CapEx projected at $80M-$90M.
Lugano delivered exceptional 2024 results with 76.4% EBITDA growth, and CODI plans to open three new Lugano salons in 2025, while continuing to focus on long-term shareholder value creation.